Oxycodon-Hcl Beta (Oxycodone Hydrochloride)

Oxycodone Hydrochloride is used for pain management across several clinical pathways.

• Acute postoperative pain: Provides effective relief following surgical procedures.
• Cancer‑related pain: Helps control persistent pain associated with malignant disease.
• Chronic non‑cancer pain: Reduces pain intensity in long‑term conditions such as osteoarthritis.
• Severe traumatic injury pain: Alleviates intense pain from major injuries.
• Palliative care pain: Improves comfort in end‑of‑life situations.

• Oxycodone Hydrochloride acts as a full agonist at the µ‑opioid receptors in the central nervous system. By binding to these receptors, it inhibits the transmission of nociceptive signals and alters pain perception, producing analgesia. The drug also influences descending pain pathways, contributing to its overall analgesic effect.

Oxycodone Hydrochloride may cause a range of adverse reactions.

Common Side Effects

• Nausea and vomiting
• Constipation
• Drowsiness or sedation
• Dizziness
• Dry mouth
• Sweating

Serious or Rare Side Effects

• Respiratory depression
• Severe hypotension
• Seizures
• Allergic reactions such as rash
• Dependence or withdrawal syndrome
• Adrenal insufficiency

When using Oxycodone Hydrochloride, several precautions should be considered.

• Assess pain severity: Confirm that opioid therapy is appropriate for the level of pain.
• Monitor for respiratory depression: Observe breathing rate and depth, especially after dose initiation.
• Evaluate renal and hepatic function: Adjust dosing in patients with impaired organ function.
• Avoid concurrent CNS depressants: Reduce risk of additive sedation and respiratory effects.
• Educate patients on dependence risk: Discuss signs of tolerance and withdrawal.
• Store at below 25°C: keep in the original packaging, protect from moisture and light.

Oxycodone Hydrochloride can interact with several medicines, requiring careful management.

Major Interactions (Avoid)

• Concurrent use with other strong opioids: Increases risk of respiratory depression and overdose.
• Benzodiazepines or barbiturates: Potentiates sedation and respiratory depression.
• Monoamine oxidase inhibitors (MAOIs): May cause severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): Elevates oxy‑cocaine  
• CYP3A4 inducers: Reduces oxy‑cocaine  
• Anticholinergic agents: May worsen constipation.
• Alcohol: Enhances central nervous system depression.
• Antihistamines: Increases drowsiness.